Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
RESEARCH TOOLSreports
Holding AVIR?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -30.93M | $ -40.28M | $ -69.81M | - | $ -40.78M |
| EBITDA | $ -30.82M | $ -36.69M | $ -69.70M | - | $ -40.68M |
| Net Income Common Stockholders | $ -31.15M | $ -40.52M | $ -63.17M | $ -39.16M | $ -33.14M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 482.81M | $ 502.21M | $ 541.49M | $ 578.11M | $ 595.13M |
| Total Assets | $ 490.96M | $ 510.38M | $ 553.03M | $ 594.97M | $ 608.08M |
| Total Debt | $ 1.83M | $ 2.02M | $ 2.21M | $ 2.40M | $ 2.58M |
| Net Debt | $ -480.98M | $ -500.19M | $ -539.28M | $ -575.70M | $ -592.54M |
| Total Liabilities | $ 32.44M | $ 33.91M | $ 48.66M | $ 39.78M | $ 26.34M |
| Stockholders Equity | $ 458.52M | $ 476.47M | $ 504.37M | $ 555.19M | $ 581.73M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -23.04M | $ -42.20M | $ -39.87M | - | $ -17.59M |
| Operating Cash Flow | $ -23.04M | $ -42.20M | $ -39.87M | $ -21.83M | $ -17.59M |
| Investing Cash Flow | $ -122.01M | $ 124.69M | $ 56.80M | $ 27.77M | $ -58.51M |
| Financing Cash Flow | $ 117.00K | - | $ 150.00K | - | $ 92.00K |